基于机器学习的查喘生物标志物和相关的免疫透
Xiaoying Zhong1,2,3, Jingjing Song1,2, Changyu Lei4
1Allergy and Clinical Immunology Center, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Frontiers in allergy
|February 18, 2025
概括
机器学习发现了13个新的喘基因,以改善诊断. 这些基因标记物,包括CEACAM5和CLCA1,在预测喘方面显示出临床应用的前景.
科学领域:
- 基因组学和生物信息学
- 计算生物学 计算生物学
- 免疫学 免疫学 免疫学
背景情况:
- 全球喘患病率正在上升,这对公众健康构成了重大挑战.
- 精确的喘诊断和预测标记对于有效管理至关重要.
- 现有的诊断方法可能缺乏早期检测的特异性和敏感性.
研究的目的:
- 利用机器学习来识别新的喘特异性基因.
- 开发一种基于基因的方法来预测和诊断喘.
- 探索已识别的喘相关基因的功能作用和临床相关性.
主要方法:
- 使用机器学习算法 (SVM-RFE,LASSO) 分析公开的基因表达数据.
- 对差异表达基因 (DEGs) 的功能丰富分析 (基因本体学,KEGG通路).
- 使用卵胺诱导的喘小鼠模型和转录组测序进行验证.
主要成果:
- 他们发现了13个特定的喘基因,包括CEACAM5,POSTN和CLCA1.
- 丰富分析显示了与免疫细胞功能和代谢途径的关联.
- 在喘小鼠中增加NOS2和CLCA1表达反映了人类患者的发现.
结论:
- 已经确定了用于喘预测和诊断的新型基因标记物.
- 这些基因具有临床应用和进一步验证的潜力.
- 这项研究为开发有针对性的喘诊断工具提供了基础.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
231
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
231